Literature DB >> 1770373

Results of cementless total knee arthroplasty in an older rheumatoid arthritis population.

R A Armstrong1, L A Whiteside.   

Abstract

Fifty-five total knee arthroplasties (TKAs) in thirty-nine adult (mean age, 62 years) patients with rheumatoid arthritis were studied prospectively for a period of 1-7 years. All of the procedures were performed using cementless fixation of the tibial and femoral components. The Knee Society clinical rating system mean knee scores increased 56 points after operation (mean, 88 points), and the mean functional scores increased 28 points (mean, 64 points). Two revisions (4%) have been required, one for secondary late infection and one for failure of a cementless metal-backed patellar component. Good bone stock was retained in both, allowing for uneventful cementless revision. Forty-two arthroplasties (76%) were completely pain-free, twelve (22%) had mild, occasional discomfort with weight-bearing, and one (2%) had moderate pain at last examination. In this older rheumatoid population, cementless TKA offers good or excellent early clinical results and excellent preservation of bone stock should revision become necessary.

Entities:  

Mesh:

Year:  1991        PMID: 1770373     DOI: 10.1016/s0883-5403(06)80188-9

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  3 in total

1.  Average 10.1-year follow-up of cementless total knee arthroplasty in patients with rheumatoid arthritis.

Authors:  Young Kyun Woo; Ki Won Kim; Jin Wha Chung; Hwa Sung Lee
Journal:  Can J Surg       Date:  2011-06       Impact factor: 2.089

2.  Clinical results of bone ingrowth TKA in patients with rheumatoid arthritis.

Authors:  Roberto Viganó; Leo A Whiteside; Marcel Roy
Journal:  Clin Orthop Relat Res       Date:  2008-07-24       Impact factor: 4.176

3.  Bone mineral density assessment by DXA in rheumatic patients with end-stage osteoarthritis undergoing total joint arthroplasty.

Authors:  Moritz Mühlenfeld; André Strahl; Ulrich Bechler; Nico Maximilian Jandl; Jan Hubert; Tim Rolvien
Journal:  BMC Musculoskelet Disord       Date:  2021-02-11       Impact factor: 2.362

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.